July 29, 5:55 AM
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
July 27, 6:06 PM
May 17, 7:17 AM
HC Wainwright & Co. analyst Ed Arce maintains Galectin Therapeutics (NASDAQ:GALT) with a Buy and lowers the price target from $14 to $11.
May 16, 8:09 AM
Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.17) per share. This is a 54.55 percent decrease over losses of $(0.11) per share from the same period last year.
April 14, 5:48 PM